References
- Gotlib J, Cools J. Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias. Leukemia 2008;22:1999–2010.
- Jones AV, Cross NC. Oncogenic derivatives of platelet-derived growth factor receptors. Cell Mol Life Sci 2004;61:2912–2923.
- Macdonald D, Cross NC. Chronic myeloproliferative disorders: the role of tyrosine kinases in pathogenesis, diagnosis and therapy. Pathobiology 2007;74:81–88.
- Reiter A, Walz C, Watmore A, et al The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2. Cancer Res 2005;65:2662–2667.
- Gotlib J, Cross NC, Gilliland DG. Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapy. Best Pract Res Clin Haematol 2006;19:535–569.
- Cools J, DeAngelo DJ, Gotlib J, et al A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003;348:1201–1214.
- Stover EH, Chen J, Folens C, et al Activation of FIP1L1-PDGFRalpha requires disruption of the juxtamembrane domain of PDGFRalpha and is FIP1L1-independent. Proc Natl Acad Sci USA 2006;103:8078–8083.
- Buchdunger E, Zimmermann J, Mett H, et al Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res 1996;56:100–104.
- Elling C, Erben P, Walz C, et al Novel PDGFRA point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia in vitro and in vivo. Blood (ASH Annual Meeting Abstracts) 2009;114(Suppl. 1): (Abstract 767).
- Heinrich MC, Corless CL, Duensing A, et al PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003;299:708–710.
- Martinho O, Longatto-Filho A, Lambros MB, et al Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas. Br J Cancer 2009;101:973–982.
- Russell MR, Jamieson WL, Dolloff NG, Fatatis A. The alpha-receptor for platelet-derived growth factor as a target for antibody-mediated inhibition of skeletal metastases from prostate cancer cells. Oncogene 2009;28:412–421.
- Mosselman S, Looijenga LH, Gillis AJ, et al Aberrant platelet-derived growth factor alpha-receptor transcript as a diagnostic marker for early human germ cell tumors of the adult testis. Proc Natl Acad Sci USA 1996;93:2884–2888.
- Oseini AM, Roberts LR. PDGFRalpha: a new therapeutic target in the treatment of hepatocellular carcinoma? Expert Opin Ther Targets 2009;13:443–454.
- Vardiman JW, Thiele J, Arber DA, et al The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009;114:937–951.
- Score J, Curtis C, Waghorn K, et al Identification of a novel imatinib responsive KIF5B-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophilia. Leukemia 2006;20:827–832.
- Erben P, Gosenca D, Muller MC, et al Screening for diverse PDGFRA or PDGFRB by fusion genes is facilitated by generic quantitative RT–PCR. Haematologica 2010;95:738–744.
- Griffin JH, Leung J, Bruner RJ, Caligiuri MA, Briesewitz R. Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome. Proc Natl Acad Sci USA 2003;100:7830–7835.
- Minato Y, Tashiro E, Kanai M, Nihei Y, Kodama Y, Imoto M. Transcriptional regulation of a new variant of human platelet-derived growth factor receptor alpha transcript by E2F-1. Gene 2007;403:89–97.
- Watzinger F, Lion T. Multiplex PCR for quality control of template RNA/cDNA in RT-PCR assays. Leukemia 1998;12:1984–1986.
- Aranaz P, Ormazábal C, Hurtado C, et al A new potential oncogenic mutation in the FERM domain of JAK2 in BCR-ABL1-negative and V617F-negative chronic myeloproliferative neoplasms revealed by a comprehensive screening of 17 tyrosine kinase coding genes. Cancer Genet Cytogenet 2010;199:1–8.
- Mosselman S, Claesson-Welsh L, Kamphuis JS, van Zoelen EJ. Developmentally regulated expression of two novel platelet-derived growth factor alpha-receptor transcripts in human teratocarcinoma cells. Cancer Res 1994;54:220–225.
- Novo FJ, de Mendibil IO, Vizmanos JL. TICdb: a collection of gene-mapped translocation breakpoints in cancer. BMC Genomics 2007;8:33.